UCB(UCB)
UCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.12B | $1.17B |
| Low | $1.09B | $1.13B |
| High | $1.14B | $1.21B |
| EBITDA Avg | $375M | $392M |
| Low | $365M | $379M |
| High | $381M | $405M |
| EBIT Avg | $345M | $361M |
| Low | $336M | $349M |
| High | $351M | $373M |
| Net Income Avg | $366M | $396M |
| Low | $348M | $389M |
| High | $383M | $404M |
| EPS Avg | $2.99 | $3.24 |
| Low | $2.86 | $3.19 |
| High | $3.14 | $3.31 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $283M | $284M | $281M | $290M | $298M | $302M |
| Low | $246M | $262M | $260M | $268M | $276M | $279M |
| High | $304M | $296M | $294M | $303M | $312M | $316M |
| EBITDA Avg | $95M | $95M | $94M | $97M | $100M | $101M |
| Low | $82M | $88M | $87M | $90M | $92M | $93M |
| High | $102M | $99M | $98M | $101M | $104M | $106M |
| EBIT Avg | $87M | $87M | $87M | $89M | $92M | $93M |
| Low | $76M | $81M | $80M | $83M | $85M | $86M |
| High | $94M | $91M | $91M | $93M | $96M | $97M |
| Net Income Avg | $92M | $92M | $90M | $96M | $102M | $103M |
| Low | $90M | $83M | $82M | $87M | $92M | $93M |
| High | $94M | $97M | $96M | $102M | $108M | $110M |
| EPS Avg | $0.76 | $0.76 | $0.75 | $0.80 | $0.84 | $0.86 |
| Low | $0.75 | $0.68 | $0.68 | $0.72 | $0.76 | $0.77 |
| High | $0.78 | $0.80 | $0.79 | $0.84 | $0.89 | $0.91 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |